Gregory Stoloff

504 total citations
14 papers, 415 citations indexed

About

Gregory Stoloff is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Gregory Stoloff has authored 14 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Gregory Stoloff's work include Influenza Virus Research Studies (9 papers), Immunotherapy and Immune Responses (5 papers) and vaccines and immunoinformatics approaches (4 papers). Gregory Stoloff is often cited by papers focused on Influenza Virus Research Studies (9 papers), Immunotherapy and Immune Responses (5 papers) and vaccines and immunoinformatics approaches (4 papers). Gregory Stoloff collaborates with scholars based in United Kingdom, United States and Norway. Gregory Stoloff's co-authors include Wilson Caparrós‐Wanderley, Olga Pleguezuelos, Stuart Robinson, Ana M. Fernández, Sally Hunsberger, Emma L. James, Matthew J. Memoli, Luz Angela Rosas, Adriana Cervantes-Medina and Fredrik Oftung and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and European Journal of Immunology.

In The Last Decade

Gregory Stoloff

13 papers receiving 397 citations

Peers

Countries citing papers authored by Gregory Stoloff

Since Specialization

Citations

This map shows the geographic impact of Gregory Stoloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Stoloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Stoloff more than expected).

Fields of papers citing papers by Gregory Stoloff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Stoloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Stoloff. The network helps show where Gregory Stoloff may publish in the future.

Co-authorship network of co-authors of Gregory Stoloff

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Stoloff. A scholar is included among the top collaborators of Gregory Stoloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Stoloff. Gregory Stoloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD) 2024 ·Pharmaceutics ·Edward Chesney, Ndaba Mazibuko, Dominic Oliver, Amedeo Minichino, (unknown), (unknown), Thomas J. Reilly, (unknown), Matilda Kråkström, Alex M. Dickens, Matej Orešič, Eric M. Lynch, Gregory Stoloff, Mitul A. Mehta, Philip McGuire	1
2	Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial 2022 ·EBioMedicine ·DeAnna Friedman-Klabanoff, Megan Birkhold, (unknown), Timothy R. Wilson, Claudio Meneses, Joshua R. Lacsina, Fabiano Oliveira, Shaden Kamhawi, Jesús G. Valenzuela, Sally Hunsberger, Allyson Mateja, Gregory Stoloff, Olga Pleguezuelos, Matthew J. Memoli, Matthew B. Laurens	15
3	FLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-γ and Granzyme B ELISpot Assay 2022 ·Vaccines ·Fredrik Oftung, Lisbeth Meyer Næss, Ida Laake, Gregory Stoloff, Olga Pleguezuelos	8
4	Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial 2020 ·The Lancet ·Jessica E. Manning, Fabiano Oliveira, Iliano V. Coutinho-Abreu, (unknown), Claudio Meneses, Shaden Kamhawi, Holly Ann Baus, Alison Han, Lindsay Czajkowski, Luz Angela Rosas, Adriana Cervantes-Medina, Rani Athota, Susan Reed, Allyson Mateja, Sally Hunsberger, Emma L. James, Olga Pleguezuelos, Gregory Stoloff, Jesús G. Valenzuela, Matthew J. Memoli	45
5	Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study 2020 ·npj Vaccines ·Olga Pleguezuelos, Emma L. James, Ana M. Fernández, Victor Lopes, Luz Angela Rosas, Adriana Cervantes-Medina, (unknown), (unknown), (unknown), Wenjuan Gu, Sally Hunsberger, Jeffery K. Taubenberger, Gregory Stoloff, Matthew J. Memoli	61
6	Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults 2020 ·Annals of Internal Medicine ·Olga Pleguezuelos, Joep Dille, (unknown), Fredrik Oftung, Hubert G.M. Niesters, Md. Atiqul Islam, Lisbeth Meyer Næss, Olav Hungnes, (unknown), (unknown), (unknown), Emma L. James, Henderik W. Frijlink, Gregory Stoloff, P. H. P. Groeneveld, Eelko Hak	25
7	Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial 2017 ·BMC Infectious Diseases ·Eva van Doorn, Olga Pleguezuelos, Heng Liu, Ana M. Fernández, (unknown), Gregory Stoloff, Fredrik Oftung, Stephen Norley, Anke Huckriede, Henderik W. Frijlink, Eelko Hak	30
8	A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans 2015 ·Clinical and Vaccine Immunology ·Olga Pleguezuelos, Stuart Robinson, Ana M. Fernández, Gregory Stoloff, Alex Mann, Anthony Gilbert, Ganesh Balaratnam, Tom Wilkinson, Rob Lambkin‐Williams, John Oxford, Wilson Caparrós‐Wanderley	55
9	Meta-Analysis and Potential Role of Preexisting Heterosubtypic Cellular Immunity Based on Variations in Disease Severity Outcomes for Influenza Live Viral Challenges in Humans 2015 ·Clinical and Vaccine Immunology ·Olga Pleguezuelos, Stuart Robinson, Ana M. Fernández, Gregory Stoloff, Wilson Caparrós‐Wanderley	11
10	Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation 2013 ·Virology Journal ·Olga Pleguezuelos, Gregory Stoloff, Wilson Caparrós‐Wanderley	3
11	Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial 2013 ·Vaccine ·Marta Boffito, Julie Fox, Christine Bowman, Martin Fisher, Chloe Orkin, Edmund Wilkins, Akil Jackson, Olga Pleguezuelos, Stuart Robinson, Gregory Stoloff, Wilson Caparrós‐Wanderley	17
12	Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial 2012 ·Vaccine ·Olga Pleguezuelos, Stuart Robinson, Gregory Stoloff, Wilson Caparrós‐Wanderley	73
13	Induction of protective T cell immunity against influenza using a novel peptide vaccine 2012 ·Tom Wilkinson, Olga Pleguezuelos, Stuart Robinson, Gregory Stoloff, (unknown), John Oxford, Alex Mann, Anthony Gilbert, Wilson Caparrós‐Wanderley	2
14	Synthetic multi‐epitope peptides identified in silico induce protective immunity against multiple influenza serotypes 2007 ·European Journal of Immunology ·Gregory Stoloff, Wilson Caparrós‐Wanderley	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact